Circulation, Vol 52, 162-169, Copyright © 1975 by American Heart Association
JR Margolis, HC Strauss, HC Miller, M Gilbert and AG Wallace
Digoxin, in a common clinical dose and at a low serum level, brought out
severe manifestations of sinus node dysfunction in a patient who had
previously undergone successful mitral valve replacement. This report
presents the results of extensive clinical and electrophysiologic studies
of this patient before and after a digoxin challenge. In the absence of
cardiac glycoside, the only demonstrable abnormalities of sinus node
function were mild resting sinus bradycardia and failure to respond to
atropine administration. Responses to isoproterenol administration,
programmed premature atrial stimulation, and overdrive pacing at several
cycle lengths were normal. Following the administration of intravenous
digoxin, 1.025 mg/24 hrs, the resting sinus cycle length increased and the
response to overdrive pacing became markedly abnormal. The latter was
followed by sinus pauses in excess of six seconds, even at relatively slow
overdrive pacing rates. The electrophysiologic and clinical implications of
these data are discussed. It is suggested that despite previous reports
that digitalis preparations are relatively well tolerated by patients with
sick sinus syndrome, caution should be used when administering these drugs
to this group of patients.
ARTICLES
Digitalis and the sick sinus syndrome. Clinical and electrophysiologic documentation of severe toxic effect on sinus node function
This article has been cited by other articles:
![]() |
R. H. Falk Proarrhythmia in Patients Treated for Atrial Fibrillation or Flutter Ann Intern Med, July 15, 1992; 117(2): 141 - 150. [Abstract] [PDF] |
||||
![]() |
M. A. Alpert and G. C. Flaker Arrhythmias Associated With Sinus Node Dysfunction: Pathogenesis, Recognition, and Management JAMA, October 28, 1983; 250(16): 2160 - 2166. [Abstract] [PDF] |
||||
![]() |
A. B. Chokshi, H. S. Friedman, M. Malach, B. C. Vasavada, and S. J. Bleicher Impact of Peer Review in Reduction of Permanent Pacemaker Implantations JAMA, August 14, 1981; 246(7): 754 - 757. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1975 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |